Literature DB >> 8132646

Identification of bacteriophage phi 29 prohead RNA domains necessary for in vitro DNA-gp3 packaging.

R J Reid1, J W Bodley, D Anderson.   

Abstract

Functional domains of the bacteriophage phi 29 prohead RNA (pRNA) that are essential for in vitro packaging of DNA-gp3 into the prohead were mapped using pRNA mutants. Oligonucleotide-directed mutant pRNAs were produced that contained deletions and sequence alterations but were predicted to retain the overall secondary structure of wild-type pRNA. Mutant pRNAs were compared to wild-type pRNA for prohead binding in a competition assay and for DNA packaging in the defined in vitro system. The prohead binding site was previously localized to residues 22-84 on the 120-residue domain I of pRNA by ribonuclease footprinting (Reid, R. J. D., Bodley, J. W., and Anderson, D. (1994) J. Biol. Chem. 269, 5157-5162). Mutations of pRNA within the prohead binding site resulted in substantial loss of prohead binding capacity, while mutations outside of the footprint had moderate effects on prohead binding. DNA-gp3 packaging activity was correlated with pRNA binding activity for mutations within the footprint. This mutational analysis showed that both sequence and secondary structure of residues 40-91 of pRNA were crucial for prohead binding and that elements of the A helix formed from residues 1-28 and 117-92 were needed for DNA packaging functions other than prohead binding.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132646

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Structure of the bacteriophage phi29 DNA packaging motor.

Authors:  A A Simpson; Y Tao; P G Leiman; M O Badasso; Y He; P J Jardine; N H Olson; M C Morais; S Grimes; D L Anderson; T S Baker; M G Rossmann
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

Review 2.  RNA nanotechnology: engineering, assembly and applications in detection, gene delivery and therapy.

Authors:  Peixuan Guo
Journal:  J Nanosci Nanotechnol       Date:  2005-12

3.  DNA packaging motor assembly intermediate of bacteriophage phi29.

Authors:  Jaya S Koti; Marc C Morais; Raj Rajagopal; Barbara A L Owen; Cynthia T McMurray; Dwight L Anderson
Journal:  J Mol Biol       Date:  2008-04-20       Impact factor: 5.469

4.  Different sequences show similar quaternary interaction stabilities in prohead viral RNA self-assembly.

Authors:  Xiaobo Gu; Susan J Schroeder
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

5.  Assembly mechanism of the sixty-subunit nanoparticles via interaction of RNA with the reengineered protein connector of phi29 DNA-packaging motor.

Authors:  Feng Xiao; Borries Demeler; Peixuan Guo
Journal:  ACS Nano       Date:  2010-06-22       Impact factor: 15.881

6.  Dual-channel single-molecule fluorescence resonance energy transfer to establish distance parameters for RNA nanoparticles.

Authors:  Dan Shu; Hui Zhang; Roman Petrenko; Jarek Meller; Peixuan Guo
Journal:  ACS Nano       Date:  2010-10-18       Impact factor: 15.881

Review 7.  Ultrastable pRNA hexameric ring gearing hexameric phi29 DNA-packaging motor by revolving without rotating and coiling.

Authors:  Chad Schwartz; Peixuan Guo
Journal:  Curr Opin Biotechnol       Date:  2013-05-14       Impact factor: 9.740

8.  Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology.

Authors:  Daniel W Binzel; Yi Shu; Hui Li; Meiyan Sun; Qunshu Zhang; Dan Shu; Bin Guo; Peixuan Guo
Journal:  Mol Ther       Date:  2016-04-29       Impact factor: 11.454

9.  Complete inhibition of virion assembly in vivo with mutant procapsid RNA essential for phage phi 29 DNA packaging.

Authors:  M Trottier; C Zhang; P Guo
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs.

Authors:  Yi Shu; Farzin Haque; Dan Shu; Wei Li; Zhenqi Zhu; Malak Kotb; Yuri Lyubchenko; Peixuan Guo
Journal:  RNA       Date:  2013-04-19       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.